Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study is testing the safety and early effectiveness of a new two-drug combination (ZG005 plus gecacitinib) for people with advanced non-small cell lung cancer. It is for patients whose cancer has continued to grow despite previous immunotherapy. The goal is to see if this co…

This study is testing whether a new combination of two drugs, ZG006 and ZG005, is safe and effective for people with advanced small cell lung cancer or neuroendocrine carcinoma. It will involve about 350 adult participants to see if the drug combo can shrink tumors and control th…

This study is testing a new combination of two drugs, ZG005 and gecacitinib, for women with advanced cervical cancer. The main goals are to find a safe dose and see if the treatment can shrink tumors. It will enroll about 120 participants to gather initial data on safety and effe…

This early-stage study is testing a new drug called ZG006 for people with advanced small cell lung cancer or neuroendocrine carcinoma who have run out of standard treatment options. The main goals are to find the safest and most effective dose and to see how well the drug works a…

This early-stage study is testing a new combination of two drugs, ZGGS18 and ZG005, for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest and most effective dose and to see if the treatment can shrink tumors. T…

This study is testing a new two-drug combination (ZG005 and gecacitinib) for people with lymphoma that has returned or hasn't responded to previous treatments. The first part aims to find a safe and effective dose, while the second part will measure how well the combination works…

This study is testing whether an experimental drug called ZG006 helps people with relapsed small cell lung cancer live longer than standard chemotherapy. The trial will enroll 420 adults whose cancer has returned after previous treatment. Researchers will directly compare ZG006 a…

This study is testing whether the experimental drug ZG005 can help control advanced solid tumors in people who haven't responded to standard treatments. The trial will enroll 100 adults with various advanced cancers to see how well the drug works and how safe it is. Researchers w…

This study is testing a new drug called ZG006 for people with advanced small cell lung cancer or other neuroendocrine cancers. The first part aims to find a safe dose, and the second part will see how well the drug works at controlling the cancer. Researchers will measure how man…

This is an early-stage study to find a safe dose and see how the body handles a new drug called ZGGS18. It is for people with advanced solid tumors who have no other standard treatments left. The main goals are to check for side effects and see how the drug moves through the body…